BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31655604)

  • 1. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β.
    Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C
    J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
    Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
    Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
    Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G
    Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
    Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
    Zeng YT; Liu XF; Yang WT; Zheng PS
    Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.
    Goto M; Osada S; Imagawa M; Nishizuka M
    Sci Rep; 2017 Nov; 7(1):16365. PubMed ID: 29180690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of RhoE Expression Enhances TGF-β-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells.
    Nishizuka M; Komada R; Imagawa M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
    Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
    Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
    Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
    Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
    Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
    Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway.
    Fan Q; Qiu MT; Zhu Z; Zhou JH; Chen L; Zhou Y; Gu W; Wang LH; Li ZN; Xu Y; Cheng WW; Wu D; Bao W
    Oncol Rep; 2015 Oct; 34(4):1787-94. PubMed ID: 26239019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway.
    Liu P; Pei JJ; Li L; Li JW; Ke XP
    Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.